Načítá se...
A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19).
The Coronavirus Disease 2019 (COVID-19) global pandemic has had a profound, lasting impact on the world’s population. A key aspect to providing care for those with COVID-19 and checking its further spread is early and accurate diagnosis of infection, which has been generally done via methods for amp...
Uloženo v:
| Vydáno v: | medRxiv |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Cold Spring Harbor Laboratory
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941646/ https://ncbi.nlm.nih.gov/pubmed/33688669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.02.09.21251427 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|